1. Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer
   Peizhen Geng et al, 2023, Front. Cell Dev. Biol. CrossRef
2. Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
   Mingze He et al, 2023, Heliyon CrossRef
3. Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer
   Hong Yun Ma et al, 2023, CIMB CrossRef
4. Efficient combination of radiotherapy and CAR-T – A systematic review
   Wojciech Szlasa et al, 2024, Biomedicine & Pharmacotherapy CrossRef
5. Prospects of Synergy: Local Interventions and CAR T Cell Therapy in Solid Tumors
   Anne Holtermann et al, 2024, BioDrugs CrossRef
6. Metronidazole-modified Au@BSA nanocomposites for dual sensitization of radiotherapy in solid tumors
   Qijun Du et al, 2024, J. Mater. Chem. B CrossRef
7. Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
   Yun Chang et al, 2024, Bioactive Materials CrossRef
8. The role of CD95 in modulating CAR T-cell therapy: Challenges and therapeutic opportunities in oncology
   Asif Ahmad Bhat et al, 2025, International Immunopharmacology CrossRef
9. Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
   Desh Deepak Singh et al, 2024, Front. Immunol. CrossRef
10. Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy
    Eric Aniogo et al, 2024, Front. Immunol. CrossRef